Knowledge (XXG)

Ossamycin

Source 📝

221: 86: 420: 244:
InChI=1S/C49H85NO14/c1-11-34(51)26-35-19-17-24-48(62-35)28-37-30(2)38(63-48)29-49(58)33(27-45(5,6)64-49)18-15-13-12-14-16-23-46(7,56)44(55)42(61-40-21-20-36(50(9)10)32(4)59-40)41(53)31(3)43(54)47(8,57)25-22-39(52)60-37/h15,18,22,25,30-38,40-44,51,53-58H,11-14,16-17,19-21,23-24,26-29H2,1-10H3/b18-15+,25-22+/t30-,31+,32?,33+,34+,35+,36?,37-,38-,40?,41+,42-,43-,44+,46+,47+,48+,49-/m0/s1
415:
Polyketides members in this family have very similar skeleton which means they share a common pathway for their biosynthesis. However, ossamycin modular PKS is rare and unique since its programmed iteration is required to assemble its product considering that only 14 extension modules have to
416:
accomplish 15 cycles of polyketide chain extension in ossamycin. And cytochrome P450 enzymes are involved in post-PKS oxidation of the ossamycin macrocycle. Unusual 2,3,4,6-deoxyaminohexose sugar L-ossamine need to be attached to C-8 of the ossamycin macrocycle in tailoring stage.
427: 361:
which is featured with a 6,6-spiroacetal (1,7-dioxaspiro-undecanyl) moiety connected to one side of the macrocycle. Widely-studied 26-membered oligomycins/rutamycins, 24-membered dunaimycins, and 22-membered cytovaricin are also in this family.
382:
polyketide and a potent inhibitor of the F0 component of mitochondrial F1F0-ATPase, which were shown to be among the top 0.1% most cell line selective cytotoxic agents of 37,000 molecules tested against the 60 human cancer cell lines of the
464:
Hochlowski JE, Mullaly MM, Brill GM, Whittern DN, Buko AM, Hill P, et al. Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures. J. Antibiot. 1991;
24: 483:
Arthur R. Salomon, David W. Voehringer, Leonard A. Herzenberg, and Chaitan Khosla.Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F0F1-ATPase. PNAS. 2000; 97(26),
399:. Studies in 1969 showed that ossamycin contained an unusual aminodeoxysaccharide that was given the name, ossamine. After nearly 30 years in 1995, its three-dimensional structure and relative 455:
Kobayashi K, Nishino C, Ohya J, Sato S, Shiobara Y, Nishimoto N. Oligomycin E, a new antitumor antibiotic produced by Streptomyces sp. MCI-2225. J. Antibiot. 1987; 40:1053–1057.
40:(1S,3S,6'R,7S,8E,15R,16R,17S,18R,19R,20S,21R,22E,26S,28R,30R)-17-oxy-3,15,16,18,20,21-hexahydroxy-6'--5,5,15,19,21,30-hexamethylspirotriaconta-8,22-diene-28,2'-oxane]-24-one 502:
Oksana Bilyk, Markiyan Samborskyy, Peter F. Leadlay.The biosynthetic pathway to ossamycin, a macrocyclic polyketide bearing a spiroacetal moiety. PLoS ONE. 2019.14(4).
446:
Oksana Bilyk, Markiyan Samborskyy, Peter F. Leadlay.The biosynthetic pathway to ossamycin, a macrocyclic polyketide bearing a spiroacetal moiety. PLoS ONE. 2019.14(4).
493:
Herbert A. Kirst, Jon S. Mynderse, James W. Martin, et al. Structure of the Spiroketal-macrolide Ossamycin. The Journal of Antibiotics. 1996; 94(2), 162-167.
260: 235: 518: 335: 474:
Kihara T, Kusakabe H, Nakamura G, Sakurai T, Isono K. Cytovaricin, a novel antibiotic. J. Antibiot. 1981; 34:1073–1074.
199: 384: 268:
CC(C1CCC2(O1)C3((O2)C4((CC(O4)(C)C)/C=C/CCCCC(((((((/C=C/C(=O)O3)(C)O)O)C)O)OC5CCC(C(O5)C)N(C)C)O)(C)O)O)C)O
126: 404: 36: 216: 52: 146: 283: 62: 419: 400: 220: 426: 106: 329: 512: 171: 379: 351: 375: 358: 355: 314: 137: 158: 23: 354:-derived natural product belonging to a family of 22- to 26-membered 117: 328:
Except where otherwise noted, data are given for materials in their
425: 418: 182: 97: 85: 75: 395:
Ossamycin was originally isolated in 1965 from culture broths of
204: 170: 61: 397:Streptomyces hygroscopicus var. ossamyceticus 372:Streptomyces hygroscopicus var. ossamyceticus 8: 219: 145: 15: 439: 265: 240: 215: 247:Key: XGECDDPXIKFBTE-ZVNFYDRVSA-N 125: 105: 7: 161: 14: 405:single crystal X-ray diffraction 301: 295: 22: 332:(at 25 °C , 100 kPa). 304: 289: 1: 403:were totally determined by 535: 385:National Cancer Institute 326: 276: 256: 231: 45: 35: 30: 21: 519:Polyketide antibiotics 430: 423: 429: 422: 322: g·mol 18: 431: 424: 336:Infobox references 16: 344:Chemical compound 342: 341: 200:CompTox Dashboard 87:Interactive image 526: 503: 500: 494: 491: 485: 481: 475: 472: 466: 462: 456: 453: 447: 444: 321: 306: 303: 297: 291: 284:Chemical formula 224: 223: 208: 206: 174: 163: 149: 129: 109: 89: 65: 26: 19: 534: 533: 529: 528: 527: 525: 524: 523: 509: 508: 507: 506: 501: 497: 492: 488: 482: 478: 473: 469: 463: 459: 454: 450: 445: 441: 436: 413: 401:stereochemistry 393: 370:Ossamycin from 368: 345: 338: 333: 319: 309: 300: 294: 286: 272: 269: 264: 263: 252: 249: 248: 245: 239: 238: 227: 217:DTXSID801336866 209: 202: 193: 177: 164: 152: 132: 112: 92: 79: 68: 55: 41: 12: 11: 5: 532: 530: 522: 521: 511: 510: 505: 504: 495: 486: 476: 467: 457: 448: 438: 437: 435: 432: 412: 409: 392: 389: 367: 364: 343: 340: 339: 334: 330:standard state 327: 324: 323: 317: 311: 310: 307: 298: 292: 287: 282: 279: 278: 274: 273: 271: 270: 267: 259: 258: 257: 254: 253: 251: 250: 246: 243: 242: 234: 233: 232: 229: 228: 226: 225: 212: 210: 198: 195: 194: 192: 191: 187: 185: 179: 178: 176: 175: 167: 165: 157: 154: 153: 151: 150: 142: 140: 134: 133: 131: 130: 122: 120: 114: 113: 111: 110: 102: 100: 94: 93: 91: 90: 82: 80: 73: 70: 69: 67: 66: 58: 56: 51: 48: 47: 43: 42: 39: 33: 32: 28: 27: 13: 10: 9: 6: 4: 3: 2: 531: 520: 517: 516: 514: 499: 496: 490: 487: 480: 477: 471: 468: 465:44:1318–1330. 461: 458: 452: 449: 443: 440: 433: 428: 421: 417: 410: 408: 406: 402: 398: 390: 388: 386: 381: 377: 373: 365: 363: 360: 357: 353: 349: 337: 331: 325: 318: 316: 313: 312: 288: 285: 281: 280: 275: 266: 262: 255: 241: 237: 230: 222: 218: 214: 213: 211: 201: 197: 196: 189: 188: 186: 184: 181: 180: 173: 169: 168: 166: 160: 156: 155: 148: 144: 143: 141: 139: 136: 135: 128: 127:ChEMBL1713335 124: 123: 121: 119: 116: 115: 108: 104: 103: 101: 99: 96: 95: 88: 84: 83: 81: 77: 72: 71: 64: 60: 59: 57: 54: 50: 49: 44: 38: 34: 29: 25: 20: 498: 489: 484:14766-14771. 479: 470: 460: 451: 442: 414: 411:Biosynthesis 396: 394: 371: 369: 366:Medical uses 352:fermentation 347: 346: 183:RTECS number 46:Identifiers 359:polyketides 356:macrocyclic 277:Properties 107:CHEBI:77735 434:References 376:antifungal 315:Molar mass 138:ChemSpider 74:3D model ( 63:11015-84-2 53:CAS Number 37:IUPAC name 17:Ossamycin 407:studies. 380:cytotoxic 348:Ossamycin 190:RN1350000 513:Category 391:History 320:912.212 172:5351598 159:PubChem 147:8923652 374:is an 261:SMILES 118:ChEMBL 31:Names 350:is a 236:InChI 98:ChEBI 76:JSmol 378:and 205:EPA 162:CID 515:: 387:. 308:14 299:85 293:49 305:O 302:N 296:H 290:C 207:) 203:( 78:)

Index


IUPAC name
CAS Number
11015-84-2
JSmol
Interactive image
ChEBI
CHEBI:77735
ChEMBL
ChEMBL1713335
ChemSpider
8923652
PubChem
5351598
RTECS number
CompTox Dashboard
DTXSID801336866
Edit this at Wikidata
InChI
SMILES
Chemical formula
Molar mass
standard state
Infobox references
fermentation
macrocyclic
polyketides
antifungal
cytotoxic
National Cancer Institute

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.